$ELV
Elevance Health, Inc. Stock $elv

$elv Overview Financials Valuation SEC Filings Company Website

2012 Q4 Form 10-Q Financial Statement

#000119312512456839 Filed on November 07, 2012

Income Statement

Concept	2012 Q4	2012 Q3	2011 Q3
Revenue	$15.44B	$15.25B	$15.40B
YoY Change	0.79%	-0.98%	5.64%
Cost Of Revenue		$66.50M	$0.00
YoY Change
Gross Profit		$15.18B	$15.40B
YoY Change		-1.41%
Gross Profit Margin		99.56%	100.0%
Selling, General & Admin	$2.354B	$2.079B	$2.120B
YoY Change	5.66%	-1.93%	2.74%
% of Gross Profit		13.69%	13.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$193.0M	$501.0M	$152.0M
YoY Change	6.63%	229.61%	-2.56%
% of Gross Profit		3.3%	0.99%
Operating Expenses	$14.70B	$2.079B	$2.120B
YoY Change	-0.21%	-1.93%	-84.1%
Operating Profit		$1.004B	$972.6M
YoY Change		3.21%
Interest Expense	-$152.0M	$133.6M	$108.2M
YoY Change	34.51%	23.48%	-202.08%
% of Operating Profit		13.31%	11.12%
Other Income/Expense, Net
YoY Change
Pretax Income	$480.2M	$1.020B	$1.045B
YoY Change	0.42%	-2.45%	-8.07%
Income Tax	$15.00M	$334.5M	$362.0M
% Of Pretax Income	3.12%	32.81%	34.63%
Net Earnings	$464.2M	$691.2M	$683.2M
YoY Change	38.44%	1.17%	-7.55%
Net Earnings / Revenue	3.01%	4.53%	4.44%
Basic Earnings Per Share	$1.52	$2.17	$1.92
Diluted Earnings Per Share	$1.51	$2.15	$1.90
COMMON SHARES
Basic Shares Outstanding	303.7M shares	318.9M shares	356.0M shares
Diluted Shares Outstanding		321.9M shares	360.4M shares

Balance Sheet

Concept	2012 Q4	2012 Q3	2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.39B	$20.93B
YoY Change	7.03%
Cash & Equivalents	$2.475B	$2.442B	$2.508B
Short-Term Investments	$16.91B	$18.49B
Other Short-Term Assets	$1.827B	$1.876B
YoY Change	-1.7%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$29.35B	$29.64B	$1.067B
YoY Change	8.3%	2677.91%	17.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.717B	$1.537B	$1.317B
YoY Change	21.1%	16.67%	9.11%
Goodwill	$16.89B	$14.47B
YoY Change	21.87%
Intangibles	$8.666B	$8.211B
YoY Change	9.25%
Long-Term Investments	$18.30B	$21.20B	$18.96B
YoY Change	-1.05%	11.8%	0.15%
Other Assets	$486.1M	$451.9M	$1.229B
YoY Change	1.61%	-63.23%	-6.18%
Total Long-Term Assets	$29.61B	$26.18B	$51.48B
YoY Change	18.12%	-49.15%	2.71%
TOTAL ASSETS
Total Short-Term Assets	$29.35B	$29.64B	$1.067B
Total Long-Term Assets	$29.61B	$26.18B	$51.48B
Total Assets	$58.96B	$55.82B	$52.55B
YoY Change	13.02%	6.22%	2.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.099B	$2.649B	$2.815B
YoY Change	-0.8%	-5.9%	2.25%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$250.0M	$192.0M	$100.0M
YoY Change	150.0%	92.0%	0.0%
Long-Term Debt Due	$557.1M	$200.0K	$1.274B
YoY Change	-56.29%	-99.98%	80.2%
Total Short-Term Liabilities	$16.00B	$14.08B	$5.047B
YoY Change	0.61%	179.04%	5.56%
LONG-TERM LIABILITIES
Long-Term Debt	$14.17B	$13.40B	$8.622B
YoY Change	67.39%	55.37%	4.93%
Other Long-Term Liabilities	$1.013B	$957.9M	$3.251B
YoY Change	-4.04%	-70.54%	-2.75%
Total Long-Term Liabilities	$15.18B	$14.35B	$11.87B
YoY Change	59.47%	20.89%	2.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.00B	$14.08B	$5.047B
Total Long-Term Liabilities	$15.18B	$14.35B	$11.87B
Total Liabilities	$35.15B	$32.00B	$28.83B
YoY Change	21.74%	10.99%	8.1%
SHAREHOLDERS EQUITY
Retained Earnings	$12.65B	$12.56B
YoY Change	10.06%
Common Stock	$3.000M	$3.100M
YoY Change	-11.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.80B	$23.82B	$23.72B
YoY Change
Total Liabilities & Shareholders Equity	$58.96B	$55.82B	$52.55B
YoY Change	13.02%	6.22%	2.97%

Cashflow Statement

Concept	2012 Q4	2012 Q3	2011 Q3
OPERATING ACTIVITIES
Net Income	$464.2M	$691.2M	$683.2M
YoY Change	38.44%	1.17%	-7.55%
Depreciation, Depletion And Amortization	$193.0M	$501.0M	$152.0M
YoY Change	6.63%	229.61%	-2.56%
Cash From Operating Activities	$750.0M	$240.0M	$1.430B
YoY Change	1215.79%	-83.22%	59.42%
INVESTING ACTIVITIES
Capital Expenditures	-$170.0M	-$149.0M	-$127.0M
YoY Change	-8.6%	17.32%	14.41%
Acquisitions
YoY Change
Other Investing Activities	-$1.097B	-$1.169B	-$725.0M
YoY Change	-293.82%	61.24%	-1.76%
Cash From Investing Activities	-$1.267B	-$1.318B	-$853.0M
YoY Change	-432.55%	54.51%	0.47%
FINANCING ACTIVITIES
Cash Dividend Paid	$87.10M	$90.70M	$88.20M
YoY Change	1.63%	2.83%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	548.0M	1.566B	234.0M
YoY Change	-173.66%	569.23%	40.12%
NET CHANGE
Cash From Operating Activities	750.0M	240.0M	1.430B
Cash From Investing Activities	-1.267B	-1.318B	-853.0M
Cash From Financing Activities	548.0M	1.566B	234.0M
Net Change In Cash	31.00M	488.0M	811.0M
YoY Change	-110.13%	-39.83%	277.21%
FREE CASH FLOW
Cash From Operating Activities	$750.0M	$240.0M	$1.430B
Capital Expenditures	-$170.0M	-$149.0M	-$127.0M
Free Cash Flow	$920.0M	$389.0M	$1.557B
YoY Change	278.6%	-75.02%	54.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2012-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Trading Symbol TradingSymbol	WLP
	dei	Entity Central Index Key EntityCentralIndexKey	0001156039
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	WellPoint, Inc.
CY2012Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	303655451	shares
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2442100000	USD
CY2012Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	18485500000	USD
CY2012Q3	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1187400000	USD
CY2012Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	16900000	USD
CY2012Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	164900000	USD
CY2012Q3	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	3645700000	USD
CY2012Q3	us-gaap	Other Receivables OtherReceivables	847300000	USD
CY2012Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	213000000	USD
CY2012Q3	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	700900000	USD
CY2012Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	61100000	USD
CY2012Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1875500000	USD
CY2012Q3	us-gaap	Assets Current AssetsCurrent	29640300000	USD
CY2012Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	244100000	USD
CY2012Q3	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	29400000	USD
CY2012Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	1236100000	USD
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1536500000	USD
CY2012Q3	us-gaap	Goodwill Goodwill	14469100000	USD
CY2012Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8210500000	USD
CY2012Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	451900000	USD
CY2012Q3	us-gaap	Assets Assets	55817900000	USD
CY2012Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	5523200000	USD
CY2012Q3	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	60800000	USD
CY2012Q3	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2229000000	USD
CY2012Q3	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	7813000000	USD
CY2012Q3	us-gaap	Unearned Premiums UnearnedPremiums	823700000	USD
CY2012Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2648500000	USD
CY2012Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	200000	USD
CY2012Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1766600000	USD
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14083100000	USD
CY2012Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13395700000	USD
CY2012Q3	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	723200000	USD
CY2012Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2841500000	USD
CY2012Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	957900000	USD
CY2012Q3	us-gaap	Liabilities Liabilities	32001400000	USD
CY2012Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2012Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	3100000	USD
CY2012Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10869700000	USD
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12556800000	USD
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	386900000	USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	23816500000	USD
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55817900000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2201600000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	15913100000	USD
CY2011Q4	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1188100000	USD
CY2011Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	14800000	USD
CY2011Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	172000000	USD
CY2011Q4	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	3402900000	USD
CY2011Q4	us-gaap	Other Receivables OtherReceivables	943900000	USD
CY2011Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	105800000	USD
CY2011Q4	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	871400000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	424800000	USD
CY2011Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1859000000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	27097400000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	246800000	USD
CY2011Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	28800000	USD
CY2011Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	1103300000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1418100000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	13858700000	USD
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7931700000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	433600000	USD
CY2011Q4	us-gaap	Assets Assets	52118400000	USD
CY2011Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	5489000000	USD
CY2011Q4	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	55100000	USD
CY2011Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2278200000	USD
CY2011Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	7822300000	USD
CY2011Q4	us-gaap	Unearned Premiums UnearnedPremiums	926500000	USD
CY2011Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3124100000	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1274500000	USD
CY2011Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1727100000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15898700000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8420900000	USD
CY2011Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	730700000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2724000000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1055900000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	28830200000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	3400000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11679200000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11490700000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	114900000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	23288200000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52118400000	USD
CY2012Q3	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	849100000	USD
CY2012Q3	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	237900000	USD
CY2012Q3	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	26700000	USD
CY2012Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2012Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	314012463	shares
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	314012463	shares
CY2012Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2011Q4	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	937700000	USD
CY2011Q4	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	240800000	USD
CY2011Q4	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	28400000	USD
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	339372680	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	339372680	shares
CY2012Q3	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	138100000	USD
CY2012Q3	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	701000000	USD
CY2012Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	192000000	USD
CY2011Q4	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	51700000	USD
CY2011Q4	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	872500000	USD
CY2011Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	100000000	USD
CY2012Q3	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	17511100000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	15233600000	USD
CY2012Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	14037100000	USD
CY2012Q3	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	15133700000	USD
CY2012Q3	us-gaap	Net Investment Income NetInvestmentIncome	168600000	USD
CY2012Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	54600000	USD
CY2012Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2012Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	3800000	USD
CY2012Q3	us-gaap	Revenues Revenues	15353100000	USD
CY2012Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	11984800000	USD
CY2012Q3	us-gaap	Selling Expense SellingExpense	390200000	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1688400000	USD
CY2012Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2078600000	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	133600000	USD
CY2012Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	14327400000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1025700000	USD
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	334500000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	691200000	USD
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.17
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.15
CY2012Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2875
CY2011Q3	us-gaap	Revenues Revenues	15398000000	USD
CY2011Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-5900000	USD
CY2011Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	12062900000	USD
CY2011Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	22900000	USD
CY2011Q3	us-gaap	Net Investment Income NetInvestmentIncome	170900000	USD
CY2011Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	362000000	USD
CY2011Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1716600000	USD
CY2011Q3	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	15155100000	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	683200000	USD
CY2011Q3	us-gaap	Selling Expense SellingExpense	403000000	USD
CY2011Q3	us-gaap	Interest Expense InterestExpense	108200000	USD
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.90
CY2011Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2011Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2119600000	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1045200000	USD
CY2011Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	94900000	USD
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.92
CY2011Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	14181600000	USD
CY2011Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	14352800000	USD
	us-gaap	Net Investment Income NetInvestmentIncome	507000000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.63
	us-gaap	Selling Expense SellingExpense	1176500000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5149600000	USD
	us-gaap	Interest Expense InterestExpense	360300000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.70
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.8625
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	20600000	USD
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	45457200000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	35849800000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6326100000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	42336600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2191300000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3384100000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	42791500000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	232000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1192800000	USD
	us-gaap	Revenues Revenues	46175600000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-3400000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	35212900000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	41779300000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6207200000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	41913300000	USD
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	44689700000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-11000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1168300000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5001600000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.33
	us-gaap	Interest Expense InterestExpense	317700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3479700000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	33700000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.24
	us-gaap	Revenues Revenues	45393000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2311400000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.75
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	193500000	USD
	us-gaap	Selling Expense SellingExpense	1205600000	USD
	us-gaap	Net Investment Income NetInvestmentIncome	543500000	USD
CY2012Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	66500000	USD
CY2012Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	63900000	USD
CY2011Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
CY2011Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62100000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	73200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	182100000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	175500000	USD
CY2012Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	955600000	USD
CY2011Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	963100000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2928900000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2882800000	USD
CY2012Q3	us-gaap	Other Income OtherIncome	141000000	USD
CY2011Q3	us-gaap	Other Income OtherIncome	10400000	USD
	us-gaap	Other Income OtherIncome	191700000	USD
	us-gaap	Other Income OtherIncome	27600000	USD
CY2012Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	3800000	USD
CY2011Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	28800000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	24000000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	44700000	USD
CY2012Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-1000000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	6900000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	500000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	865900000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-202300000	USD
CY2011Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	2000000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-11300000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	5300000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-1200000	USD
CY2011Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	471700000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	248500000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-4400000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-600000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	19900000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-200000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2463300000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-104300000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-2300000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-10600000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	19000000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	1200000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2219000000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	168300000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	174700000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	-211500000	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	26600000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1984800000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	123700000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	474800000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	33300000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	23200000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1600000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	133200000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-446700000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-79500000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-16800000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	255300000	USD
	us-gaap	Depreciation Depreciation	72800000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	3700000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-57500000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	245100000	USD
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-102800000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	11808800000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	8433400000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1347800000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-300000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	312300000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	153700000	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	25400000	USD
	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	-171500000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	375100000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	900000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3285100000	USD
	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	30100000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1251200000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	392000000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	300000000	USD
	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	-171500000	USD
	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	-94600000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1828800000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	280000000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	86700000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	23200000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1541100000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	240500000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	229200000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	25000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1323200000	USD
	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	-128400000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	10017200000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	357200000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	107100000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2354200000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	14100000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	100000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	38400000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	719600000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	151300000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	8187100000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	703800000	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	8600000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	100000000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	386300000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-412200000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1500000	USD
	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	159700000	USD
	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	-128200000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	334400000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	139900000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	647900000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1561300000	USD
	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	658600000	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	19300000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-5100000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	219000000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	272100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1275200000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2500000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	29700000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	122100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3316500000	USD
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	747200000	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2508400000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1788800000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	992300000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	602300000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	400000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4935200000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1300000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1097400000	USD
	us-gaap	Depreciation Depreciation	71100000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	98100000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	38400000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1828800000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	283100000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	176900000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	23812600000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2354200000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	274900000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	315600000	USD
CY2011Q3	us-gaap	Stockholders Equity StockholdersEquity	23718100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	272000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	-92400000	USD
CY2012Q3	wlp	Number Of Commercial Medical Members NumberOfCommercialMedicalMembers	33500000	pure
CY2012Q3	wlp	Number Of Individuals Members NumberOfIndividualsMembers	63700000	pure
CY2012Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	50	pure
CY2012Q3	wlp	Number Of Counties In State Of Kansas Company Does Not Serve NumberOfCountiesInStateOfKansasCompanyDoesNotServe	30	pure
	wlp	Number Of Counties In New York City Metropolitan Area Company Serves As Independent Licensee NumberOfCountiesInNewYorkCityMetropolitanAreaCompanyServesAsIndependentLicensee	10	pure
	us-gaap	Nature Of Operations NatureOfOperations	<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">1</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">. Organization</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">References to the terms “we”, “our”, “us”, “WellPoint” or the “Company” used throughout these Notes to Consolidated Financial Statements refer to WellPoint, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">We are </font><font style="font-family:Times New Roman;font-size:10pt;">one of the </font><font style="font-family:Times New Roman;font-size:10pt;">largest</font><font style="font-family:Times New Roman;font-size:10pt;"> health benefits companies</font><font style="font-family:Times New Roman;font-size:10pt;"> in the United</font><font style="font-family:Times New Roman;font-size:10pt;"> States, serving </font><font style="font-family:Times New Roman;font-size:10pt;">33.5</font><font style="font-family:Times New Roman;font-size:10pt;"> medical members through our affiliated health plans and more than </font><font style="font-family:Times New Roman;font-size:10pt;">63.7</font><font style="font-family:Times New Roman;font-size:10pt;"> individuals through </font><font style="font-family:Times New Roman;font-size:10pt;">all</font><font style="font-family:Times New Roman;font-size:10pt;"> subsidiaries as of </font><font style="font-family:Times New Roman;font-size:10pt;">September 30</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">2012</font><font style="font-family:Times New Roman;font-size:10pt;">. We offer a broad spectrum of network-based managed care plans to large and small employer, individual, Medicaid and senior markets. Our managed care plans include: preferred provider organizations, or PPOs; health maintenance organizations, or HMOs; point-of-service, or POS, plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans, or CDHPs; and hospital only and limited benefit products. In addition, we provide a broad array of managed care services to self-funded customers, including </font><font style="font-family:Times New Roman;font-size:10pt;">claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. We provide an array of specialty and other </font><font style="font-family:Times New Roman;font-size:10pt;">insurance </font><font style="font-family:Times New Roman;font-size:10pt;">products and services such as</font><font style="font-family:Times New Roman;font-size:10pt;"> behavioral health benefit services, </font><font style="font-family:Times New Roman;font-size:10pt;">dental, vision, </font><font style="font-family:Times New Roman;font-size:10pt;">life and disability insurance benefits, </font><font style="font-family:Times New Roman;font-size:10pt;">radiology benefit management, analytics-driven personal health care guidance and long-term care insurance. </font><font style="font-family:Times New Roman;font-size:10pt;">We</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">also </font><font style="font-family:Times New Roman;font-size:10pt;">provide services to the Federal Government in connection with the Federal Employee Program, or FEP, and various Medicare programs.</font><font style="font-family:Times New Roman;font-size:10pt;"> Fina</font><font style="font-family:Times New Roman;font-size:10pt;">lly, we sell contact lenses, </font><font style="font-family:Times New Roman;font-size:10pt;">eye</font><font style="font-family:Times New Roman;font-size:10pt;">glasses</font><font style="font-family:Times New Roman;font-size:10pt;"> and other ocular products</font><font style="font-family:Times New Roman;font-size:10pt;"> through our recently acquired 1-800 CONTACTS, Inc., or 1-800 CONTACTS, subsidiary.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">We are an independent licensee of the Blue Cross and Blue Shield Association</font><font style="font-family:Times New Roman;font-size:10pt;">, or BCBSA, an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California; the Blue Cross and Blue Shield, or BCBS, licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding </font><font style="font-family:Times New Roman;font-size:10pt;">30</font><font style="font-family:Times New Roman;font-size:10pt;"> counties in the Kansas City area), Nevada, New Hampshire, New York (as the BCBS licensee in </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> New York City metropolitan and surrounding counties and as the Blue Cross or BCBS licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross Blue Shield, or Empire Blue Cross (in our </font><font style="font-family:Times New Roman;font-size:10pt;">New York</font><font style="font-family:Times New Roman;font-size:10pt;"> service areas). We also serve customers throughout the country as UniCare</font><font style="font-family:Times New Roman;font-size:10pt;">, and in certain California, Arizona and Nevada markets through our CareMore Health Group, Inc., or CareMore, subsidiary</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">We are licensed to conduct insurance operations in all </font><font style="font-family:Times New Roman;font-size:10pt;">50</font><font style="font-family:Times New Roman;font-size:10pt;"> states through our subsidiaries.</font></p>
CY2012Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1373900000	USD
CY2012Q3	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses1	-30500000	USD
CY2012Q3	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses1	-21800000	USD
CY2012Q3	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	19946400000	USD
CY2011Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	16440500000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1107100000	USD
CY2011Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses1	-129200000	USD
CY2011Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses1	-41600000	USD
CY2011Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	17376800000	USD
CY2012Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	18624800000	USD
CY2012Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	19946400000	USD
CY2012Q3	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	1356	pure
CY2012Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	1022800000	USD
CY2011Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	2352	pure
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2480000000	USD
CY2012Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	259000000	USD
CY2011Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	221	pure
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	356900000	USD
CY2012Q3	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	197	pure
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	364100000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	132100000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	8745700000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1309300000	USD
CY2012Q3	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	22040500000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1675800000	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	12100000	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-14700000	USD
CY2011Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	20025400000	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	-400000	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	-2800000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	167100000	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	19800000	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-21200000	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-6000000	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	10000000	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	5800000	USD
CY2012Q3	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-200000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	288500000	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	-600000	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	-8500000	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	17400000	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	USD
CY2011Q3	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-1200000	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	160700000	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	288100000	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-6100000	USD
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	284800000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	69700000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-33300000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-65600000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	29500000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	111500000	USD
CY2010Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	388700000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	64500000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-5400000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-54100000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-145600000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	41000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	14900000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	-27800000	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-600000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	1400000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	-7800000	USD
	us-gaap	Fair Value Level1 To Level2 Transfers Amount FairValueLevel1ToLevel2TransfersAmount	0	USD
	us-gaap	Fair Value Level1 To Level2 Transfers Amount FairValueLevel1ToLevel2TransfersAmount	0	USD
	us-gaap	Fair Value Level2 To Level1 Transfers Amount FairValueLevel2ToLevel1TransfersAmount	0	USD
	us-gaap	Fair Value Level2 To Level1 Transfers Amount FairValueLevel2ToLevel1TransfersAmount	0	USD
	wlp	Number Of Assets Measured At Fair Value On Nonrecurring Basis NumberOfAssetsMeasuredAtFairValueOnNonrecurringBasis	0	USD
	wlp	Number Of Assets Measured At Fair Value On Nonrecurring Basis NumberOfAssetsMeasuredAtFairValueOnNonrecurringBasis	0	USD
	wlp	Number Of Liabilities Measured At Fair Value On Nonrecurring Basis NumberOfLiabilitiesMeasuredAtFairValueOnNonrecurringBasis	0	USD
	wlp	Number Of Liabilities Measured At Fair Value On Nonrecurring Basis NumberOfLiabilitiesMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2012Q3	us-gaap	Commercial Paper CommercialPaper	829900000	USD
CY2012Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	13742100000	USD
CY2012Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.326	pure
CY2011Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.346	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.352	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.336	pure
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	30900000	USD
CY2012	wlp	Expected Material Contribution ExpectedMaterialContribution	0	USD
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1200000	USD
CY2012Q3	us-gaap	Loss Contingency Range Of Possible Loss Minimum LossContingencyRangeOfPossibleLossMinimum	0	USD
CY2012Q3	us-gaap	Loss Contingency Range Of Possible Loss Maximum LossContingencyRangeOfPossibleLossMaximum	350000000	USD
CY2012Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2012-03-23
CY2011Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2011-03-25
CY2012Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2012-03-09
CY2012Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2012-01-24
CY2011Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2011-02-22
CY2011Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2011-03-10
CY2012Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	93500000	USD
CY2011Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	91100000	USD
CY2011Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	92800000	USD
CY2012Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	95800000	USD
CY2012Q2	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2012-05-16
CY2012Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2012-06-08
CY2012Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2012-06-25
CY2011Q2	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2011-05-17
CY2011Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2011-06-10
CY2011Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2011-06-24
CY2012Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2875
CY2011Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2012Q3	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2012-07-24
CY2012Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2012-09-10
CY2012Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2012-09-25
CY2011Q3	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2011-07-26
CY2011Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2011-09-09
CY2011Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2011-09-23
CY2012Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2875
CY2012Q3	us-gaap	Payments Of Dividends PaymentsOfDividends	90700000	USD
CY2011Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2011Q3	us-gaap	Payments Of Dividends PaymentsOfDividends	88200000	USD
CY2012Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	10400000	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	28600000	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	34200000	shares
CY2012Q4	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	60.94
	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	63.85
	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	68.87
CY2012Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	634300000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00379	pure
	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	2504900000	USD
	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	5019300000	USD
CY2012Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	1870600000	USD
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1700000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-1900000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-1300000	shares
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18500000	shares
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	16100000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	62.30
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	66.24
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	45.69
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	73.52
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	63.58
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	63.30
CY2012Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	3.6	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	3.2	pure
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	92900000	USD
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	92700000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1900000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-2100000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-300000	shares
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3500000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	66.20
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	48.76
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue	65.39
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	65.29
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4000000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	56.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.01410	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.34000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00400	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm	4.1	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm	4.0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.02840	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.34000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.51
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.84
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	318900000	shares
CY2012Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3000000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	321900000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	356000000	shares
CY2011Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4400000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	360400000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	327200000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3500000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	330700000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	365300000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	5000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	370300000	shares
CY2011Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10900000	shares
CY2012Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14800000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10300000	shares
	wlp	Potentially Dilutive Restricted Stock Units Contingent On Operating Results PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults	800000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11900000	shares
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1003800000	USD
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	972600000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3208100000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3269600000	USD

Files In Submission

Name	View Source	Status
0001193125-12-456839-index-headers.html	Edgar Link	pending
0001193125-12-456839-index.html	Edgar Link	pending
0001193125-12-456839.txt	Edgar Link	pending
0001193125-12-456839-xbrl.zip	Edgar Link	pending
d432590d10q.htm	Edgar Link	pending
d432590dex1020.htm	Edgar Link	pending
d432590dex107.htm	Edgar Link	pending
d432590dex21a.htm	Edgar Link	pending
d432590dex311.htm	Edgar Link	pending
d432590dex312.htm	Edgar Link	pending
d432590dex321.htm	Edgar Link	pending
d432590dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wlp-20120930.xml	Edgar Link	completed
wlp-20120930.xsd	Edgar Link	pending
wlp-20120930_cal.xml	Edgar Link	unprocessable
wlp-20120930_def.xml	Edgar Link	unprocessable
wlp-20120930_lab.xml	Edgar Link	unprocessable
wlp-20120930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELV
Elevance Health, Inc. Stock $elv

2012 Q4 Form 10-Q Financial Statement

#000119312512456839 Filed on November 07, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV Elevance Health, Inc. Stock $elv

2012 Q4 Form 10-Q Financial Statement

#000119312512456839 Filed on November 07, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV
Elevance Health, Inc. Stock $elv